Paper29659751
A Randomized, Placebo-Controlled Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Adults Aged 27 Years or Older: AIDS Clinical Trials Group Protocol A5298.
Wilkin TJ and 13 others. Clin Infect Dis, 2018. Cited by 116 papers, by iCite.
Cite this record
ConductScience Library. A Randomized, Placebo-Controlled Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Adults Aged 27 Years or Older: AIDS Clinical Trials Group Protocol A5298. Papers, record 29659751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29659751
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
A Randomized, Placebo-Controlled Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Adults Aged 27 Years or Older: AIDS Clinical Trials Group Protocol A5298.
- PubMed
- Publication types
- Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, N.I.H., Extramural
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anus Neoplasms | Major topic |
| HIV Infections | Major topic |
| Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | Major topic |
| Oropharyngeal Neoplasms | Major topic |
| Papillomavirus Infections | Major topic |
| Adult | |
| Anal Canal | |
| Brazil | |
| Double-Blind Method | |
| Early Termination of Clinical Trials | |
| Female | |
| Humans | |
| Male | |
| Medical Futility | |
| Middle Aged | |
| Mouth | |
| Papillomaviridae | |
| Vaccine Potency |
Source PubMed
Grants38
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| UM1 AI069472 | NIAID NIH HHS | United States | U01AI069472 | PubMed and NIH | NIH RePORTER |
| UM1 AI069470 | NIAID NIH HHS | United States | UM1AI069470 | PubMed and NIH | NIH RePORTER |
| UM1 AI069471 | NIAID NIH HHS | United States | U01AI069471 | PubMed and NIH | NIH RePORTER |
| UL1 TR000457 | NCATS NIH HHS | United States | UL1TR000457 | PubMed and NIH | NIH RePORTER |
| U01 AI069471 | NIAID NIH HHS | United States | U01AI069471 | PubMed and NIH | NIH RePORTER |
| UM1 AI069496 | NIAID NIH HHS | United States | UM1AI069496 | PubMed and NIH | NIH RePORTER |
| UM1 AI069439 | NIAID NIH HHS | United States | UM1AI069439 | PubMed and NIH | NIH RePORTER |
| U01 AI069503 | NIAID NIH HHS | United States | U01AI069503 | PubMed and NIH | NIH RePORTER |
| UM1 AI069412 | NIAID NIH HHS | United States | UM1AI069412 | PubMed and NIH | NIH RePORTER |
| UM1 AI106701 | NIAID NIH HHS | United States | UM1AI106701 | PubMed and NIH | NIH RePORTER |
| UM1 AI069424 | NIAID NIH HHS | United States | UM1AI069424 | PubMed and NIH | NIH RePORTER |
| U01 AI069419 | NIAID NIH HHS | United States | U01AI069419 | PubMed and NIH | NIH RePORTER |
| UM1 AI069494 | NIAID NIH HHS | United States | UM1AI069494 | PubMed and NIH | NIH RePORTER |
| UM1 AI069503 | NIAID NIH HHS | United States | U01AI069503 | PubMed and NIH | NIH RePORTER |
| UL1 TR000042 | NCATS NIH HHS | United States | UL1TR000042 | PubMed and NIH | NIH RePORTER |
| UL1 TR001111 | NCATS NIH HHS | United States | UL1TR001111 | PubMed and NIH | NIH RePORTER |
| UM1 AI069432 | NIAID NIH HHS | United States | UM1AI069432 | PubMed and NIH | NIH RePORTER |
| P30 CA016086 | NCI NIH HHS | United States | P30CA016086 | PubMed and NIH | NIH RePORTER |
| UL1 TR001082 | NCATS NIH HHS | United States | UL1TR001082 | PubMed and NIH | NIH RePORTER |
| UM1 AI069556 | NIAID NIH HHS | United States | UM1AI069556 | PubMed and NIH | NIH RePORTER |
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT01461096 | Quadrivalent HPV Vaccine to Prevent Anal HPV in HIV-infected Men and Women | Derived from the trial | Yes | ClinicalTrials.gov |
| NCT04270773 | Immunogenicity and Safety of a 9-valent Human Papillomavirus Vaccine in HIV-positive Women | Background | ClinicalTrials.gov |
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25925419 | US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. | J Natl Cancer Inst | 2015 | https://conductscience.org/library/papers/25925419 | PubMed |
| 2 | 15849533 | Increased incidence of squamous cell anal cancer among men with AIDS in the era of highly active antiretroviral therapy. | Sex Transm Dis | 2005 | https://conductscience.org/library/papers/15849533 | PubMed |
| 3 | 22291111 | Prevention of recurrent high-grade anal neoplasia with quadrivalent human papillomavirus vaccination of men who have sex with men: a nonconcurrent cohort study. | Clin Infect Dis | 2012 | https://conductscience.org/library/papers/22291111 | PubMed |
| 4 | 22454089 | Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data. | BMJ | 2012 | https://conductscience.org/library/papers/22454089 | PubMed |
| 5 | 16272481 | Analysis of the effect of DNA purification on detection of human papillomavirus in oral rinse samples by PCR. | J Clin Microbiol | 2005 | https://conductscience.org/library/papers/16272481 | PubMed |
| 6 | 19239366 | Prevalence, clearance, and incidence of anal human papillomavirus infection in HIV-infected men: the HIPVIRG cohort study. | J Infect Dis | 2009 | https://conductscience.org/library/papers/19239366 | PubMed |
| 7 | 20812850 | Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in HIV-1-infected men. | J Infect Dis | 2010 | https://conductscience.org/library/papers/20812850 | PubMed |
| 8 | 20610686 | Evaluation of transported dry and wet cervical exfoliated samples for detection of human papillomavirus infection. | J Clin Microbiol | 2010 | https://conductscience.org/library/papers/20610686 | PubMed |
| 9 | 24751181 | Human papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United States. | Emerg Infect Dis | 2014 | https://conductscience.org/library/papers/24751181 | PubMed |
| 10 | 15577408 | HIV-associated anal cancer: has highly active antiretroviral therapy reduced the incidence or improved the outcome? | J Acquir Immune Defic Syndr | 2004 | https://conductscience.org/library/papers/15577408 | PubMed |
| 11 | 29049523 | Oral Human Papillomavirus Infection: Differences in Prevalence Between Sexes and Concordance With Genital Human Papillomavirus Infection, NHANES 2011 to 2014. | Ann Intern Med | 2017 | https://conductscience.org/library/papers/29049523 | PubMed |
| 12 | 24723284 | Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in HIV-1-infected women. | Clin Infect Dis | 2014 | https://conductscience.org/library/papers/24723284 | PubMed |
| 13 | 27387669 | Human Papillomavirus-Associated Cancers - United States, 2008-2012. | MMWR Morb Mortal Wkly Rep | 2016 | https://conductscience.org/library/papers/27387669 | PubMed |
| 14 | 24235263 | Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV medicine association of the Infectious Diseases Society of America. | Clin Infect Dis | 2014 | https://conductscience.org/library/papers/24235263 | PubMed |
| 15 | 19144800 | Development and evaluation of a liquid bead microarray assay for genotyping genital human papillomaviruses. | J Clin Microbiol | 2009 | https://conductscience.org/library/papers/19144800 | PubMed |
| 16 | 11151066 | Use of buccal cells collected in mouthwash as a source of DNA for clinical testing. | Arch Pathol Lab Med | 2001 | https://conductscience.org/library/papers/11151066 | PubMed |
| 17 | 25976897 | Trends in survival after cancer diagnosis among HIV-infected individuals between 1992 and 2009. Results from the FHDH-ANRS CO4 cohort. | Int J Cancer | 2015 | https://conductscience.org/library/papers/25976897 | PubMed |
| 18 | 18614927 | Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study. | J Acquir Immune Defic Syndr | 2008 | https://conductscience.org/library/papers/18614927 | PubMed |
| 19 | 22445259 | Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. | Lancet Oncol | 2012 | https://conductscience.org/library/papers/22445259 | PubMed |
| 20 | 8841649 | A non-parametric test for interval-censored failure time data with application to AIDS studies. | Stat Med | 1996 | https://conductscience.org/library/papers/8841649 | PubMed |
Cited by81
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 116 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42807817 | HIV-associated immune remodeling in cervical cancer: implications for immunotherapy, biomarkers, and trial design. | Front Immunol | 2026 | https://conductscience.org/library/papers/42807817 | PubMed |
| 42775839 | Sexually transmitted infection syndemic interactions: Biological amplification between HIV, HSV-2, syphilis, and HPV and implications for co-treatment strategies. | Sci Prog | 2026 | https://conductscience.org/library/papers/42775839 | PubMed |
| 42726205 | [Vaccine prevention of HPV-associated diseases]. | Dermatologie (Heidelb) | 2026 | https://conductscience.org/library/papers/42726205 | PubMed |
| 42684271 | Immunogenicity and safety of prophylactic HPV vaccines in people living with HIV: A systematic review and meta-analysis. | Hum Vaccin Immunother | 2026 | https://conductscience.org/library/papers/42684271 | PubMed |
| 42649891 | Anal High-Grade Squamous Intraepithelial Lesions in People Living with HIV: A Systematic Review of Treatment Outcomes. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42649891 | PubMed |
| 42583010 | Incidence and burden of anal cancer-time to fight the growing disparities. | ESMO Gastrointest Oncol | 2026 | https://conductscience.org/library/papers/42583010 | PubMed |
| 42453776 | Evaluation of Anal Cancer Screening Among 18-to-34-Year-Old Men Who Have Sex With Men Living With HIV Over a 10-Year Period. | Open Forum Infect Dis | 2026 | https://conductscience.org/library/papers/42453776 | PubMed |
| 42070588 | Genotype distribution of human papillomavirus (HPV) types in oral gargle specimens among men living with HIV in Mexico, Brazil, and Puerto Rico: A cross-sectional study. | J Infect | 2026 | https://conductscience.org/library/papers/42070588 | PubMed |
| 41866610 | Closing the Gap: HPV Vaccination and Head and Neck Cancer Prevention. | Curr Oncol Rep | 2026 | https://conductscience.org/library/papers/41866610 | PubMed |
| 41746114 | Advances in HPV Vaccination in People Living with HIV: A Review. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/41746114 | PubMed |
| 41725297 | Long-term intraanal HPV16 infection in men having sex with men with HIV: Persistence or reinfection? | J Eur Acad Dermatol Venereol | 2026 | https://conductscience.org/library/papers/41725297 | PubMed |
| 41685810 | Nonavalent HPV vaccine to prevent recurrent anal or vulvar high-grade squamous intraepithelial lesions (VIVA trial): A randomized, double-blind, placebo-controlled trial. | Int J Cancer | 2026 | https://conductscience.org/library/papers/41685810 | PubMed |
| 41586588 | Dynamics of anal HPV infection after 9vHPV vaccination in men who have sex with men (MSM) with HIV: A prospective, controlled cohort study. | Hum Vaccin Immunother | 2026 | https://conductscience.org/library/papers/41586588 | PubMed |
| 41188885 | Ageing with HIV-1: immunological challenges for effective vaccination. | Immun Ageing | 2025 | https://conductscience.org/library/papers/41188885 | PubMed |
| 41177815 | Anal Squamous Intraepithelial Lesions: A Primer for Gastroenterologists. | Curr Gastroenterol Rep | 2025 | https://conductscience.org/library/papers/41177815 | PubMed |
| 40794702 | A Phase IV, Open-label, Single-Arm, Multicentric Clinical Trial for Evaluation of Human Papillomavirus 9vHPV Vaccine Immunogenicity in Men Who Have Sex With Men With HIV: GeSIDA Study 10 017. | Clin Infect Dis | 2026 | https://conductscience.org/library/papers/40794702 | PubMed |
| 40609265 | Design of a multicenter, randomized, double-blinded, placebo-controlled phase III trial evaluating the 9-valent human papillomavirus (HPV) vaccine to prevent persistent oral HPV infection in men living with human immunodeficiency virus: ULACNet trial 201. | Vaccine | 2025 | https://conductscience.org/library/papers/40609265 | PubMed |
| 40338823 | Vaccine effectiveness against anal HPV infection among men with HIV who have sex with men attending sexual health clinics in three United States cities, 2018-2023. | J Acquir Immune Defic Syndr | 2025 | https://conductscience.org/library/papers/40338823 | PubMed |
| 40334187 | The epidemiology and risk factors of anal and oropharyngeal human papillomavirus (HPV) in males living with human immunodeficiency virus (HIV): A protocol for systematic review and meta-analysis. | PLoS One | 2025 | https://conductscience.org/library/papers/40334187 | PubMed |
| 39976870 | Update on Vaccination Recommendations for Adults with HIV. | Curr HIV/AIDS Rep | 2025 | https://conductscience.org/library/papers/39976870 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29659751
GET https://conductscience.org/api/papers/v1/29659751/grants?page=2